Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
FDA approval · 2025-05-13FDA Approved: DOCETAXEL — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves a generic docetaxel product under an original ANDA for Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) [Phase 2]
Phase 2 study evaluating IMU-131 (HER-Vaxx) with chemotherapy or pembrolizumab in metastatic HER2-overexpressing gastric cancer; the trial w…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With Immunochemotherapy [Phase 4]
A Phase 4 clinical trial from Peking University is evaluating nanosized Megestrol Acetate combined with immunochemotherapy to treat anorexia…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Preventive Use of PIPAC in Locally Advanced Gastric Cancer. [NA]
ClinicalTrials.gov entry for preventive use of PIPAC in locally advanced gastric cancer; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)
A clinical trial update for FUGES-30 evaluating the use of indocyanine green tracer in laparoscopic gastrectomy with extended lymphadenectom…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection [NA]
The trial evaluates magnetic guided countertraction during endoscopic submucosal dissection and is currently recruiting for early gastric ca…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. [NA]
This is a prospective study (EQUITY GI) to improve quality, inclusivity, and trial participation for Black patients with gastrointestinal ca…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC [Phase 1, Phase 2]
A Phase 1/2 trial evaluating XELOX (capecitabine plus oxaliplatin) in combination with sintilimab and hyperbaric oxygen therapy for advanced…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating CAM-H2, a HER2-directed radioligand, in advanced/metastatic HER2-positive breast, gastric, and gastroesophageal…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating total neoadjuvant FLOT chemotherapy for locally advanced gastric and gastroesophageal junction cancer;…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer [Phase 2]
A Phase 2 randomized controlled trial is evaluating endoscopic cryoablation plus a PD-1 inhibitor as maintenance therapy for advanced gastri…
-
EMA approval · 2025-05-05EMA Authorised: Ecansya (previously Capecitabine Krka) (capecitabine) — Krka, d.d., Novo mesto
The EMA authorised Ecansya, a capecitabine product by Krka, as a new generic cancer treatment option for breast, colon, colorectal, and gast…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: RCT of Gastric ESD With or Without Epineprhine Added Solution [Phase 3]
A Phase 3 randomized trial evaluated gastric endoscopic submucosal dissection with versus without an epinephrine-added solution; the study s…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
An ongoing enrolling-by-invitation clinical trial evaluating AI-driven prediction of lymph node metastasis in gastric cancer using preoperat…
-
EMA approval · 2025-05-02EMA Authorised: Xeloda (capecitabine) — CHEPLAPHARM Arzneimittel GmbH
The EMA authorised CHEPLAPHARM Arzneimittel GmbH to market Xeloda (capecitabine) in the EU for several cancers, including breast, colon/colo…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality [Phase 4]
A multicenter Phase 4 randomized trial is evaluating whether Helicobacter pylori eradication plus pepsinogen testing can reduce gastric canc…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique [NA]
A prospective study from Huashan Hospital is evaluating an innovative esophagogastrostomy surgical technique for gastric cancer and adenocar…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Fluorescence Image Guided Foregut Surgery [NA]
A clinical trial led by IHU Strasbourg is currently recruiting participants to assess fluorescence image-guided foregut surgery in patients …
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer [Phase 2]
A Phase 2 trial is evaluating endoscopic cryoablation in combination with a PD-1 inhibitor for advanced gastric cancer; the study is not yet…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Perianastomotic Drain After Gastrectomy (DRAG) [NA]
The DRAG trial assessing perianastomotic drain after gastrectomy for gastric cancer has completed, with results posted on 2025-04-27.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients
A clinical trial is enrolling by invitation to develop and validate a radiomics-based AI model to predict para-aortic lymph node metastasis …
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating SBRT-LDRT with cadonilimab for advanced gastric, colorectal, and ovarian cancers with peritoneal…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS
A clinical trial update describes using liquid biopsies of circulating tumor cells and circulating tumor DNA to guide precision medicine in …